Cloxazolam
Benzodiazepine medication
- N05BA22 (WHO)
- BR: Class B1 (Psychoactive drugs)[2]
- CA: Schedule IV
- DE: Anlage III (Special prescription form required)
- UK: Class C
- US: Schedule IV
- 10-chloro-11b-(2-chlorophenyl)-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one
- 24166-13-0
Y
- 2816
- DB01553 Y
- 2714 Y
- GYL649Z0HY
- D01268 Y
- ChEMBL2107254
N
- DTXSID0022854
- Interactive image
- Clc1ccccc1C42OCCN2CC(=O)Nc3c4cc(Cl)cc3
- InChI=1S/C17H14Cl2N2O2/c18-11-5-6-15-13(9-11)17(12-3-1-2-4-14(12)19)21(7-8-23-17)10-16(22)20-15/h1-6,9H,7-8,10H2,(H,20,22)Y
- Key:ZIXNZOBDFKSQTC-UHFFFAOYSA-NY
N
Y (what is this?) (verify)Cloxazolam is a benzodiazepine derivative that has anxiolytic, sedative, and anticonvulsant properties.[3][4] It is not widely used; [3] as of August 2018 it was marketed in Belgium, Luxembourg, Portugal, Brazil, and Japan.[1] In 2019, it has been retired from the Belgian market. [5]
See also
References
- ^ a b "Cloxazolam International Brands". Drugs.com. Retrieved 13 August 2018.
- ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
- ^ a b Stolerman IP, ed. (2010). "C: Cloxazolam". Encyclopedia of Psychopharmacology. Berlin: Springer-Verlag. ISBN 978-3-540-68706-1.
- ^ Richards BL, Whittle SL, Buchbinder R (January 2012). "Muscle relaxants for pain management in rheumatoid arthritis". The Cochrane Database of Systematic Reviews. 1: CD008922. doi:10.1002/14651858.CD008922.pub2. PMID 22258993. S2CID 73769165.
- ^ "Bon à savoir". cbip.be. Retrieved 13 August 2018.
External links
- Inchem.org - Cloxazolam
- v
- t
- e
- Benzodiazepines: Adinazolam
- Alprazolam
- Bromazepam
- Camazepam
- Chlordiazepoxide
- Clobazam
- Clonazepam
- Clorazepate
- Clotiazepam
- Cloxazolam
- Diazepam#
- Ethyl loflazepate
- Etizolam
- Fludiazepam
- Halazepam
- Ketazolam
- Lorazepam#
- Medazepam
- Nordazepam
- Oxazepam
- Pinazepam
- Prazepam; Others: Alpidem‡
- Barbiturates (e.g., phenobarbital)
- Carbamates (e.g., meprobamate)
- Carisoprodol
- Chlormezanone‡
- Ethanol (alcohol)
- Etifoxine
(α2δ VDCC blockers)
- SSRIsTooltip Selective serotonin reuptake inhibitors (e.g., escitalopram)
- SNRIsTooltip Serotonin-norepinephrine reuptake inhibitors (e.g., duloxetine)
- SARIsTooltip Serotonin antagonist and reuptake inhibitors (e.g., trazodone)
- TCAsTooltip Tricyclic antidepressants (e.g., clomipramine#)
- TeCAsTooltip Tetracyclic antidepressants (e.g., mirtazapine)
- MAOIsTooltip Monoamine oxidase inhibitors (e.g., phenelzine); Others: Agomelatine
- Bupropion
- Tianeptine
- Vilazodone
- Vortioxetine
(Antiadrenergics)
- Alpha-1 blockers (e.g., prazosin)
- Alpha-2 agonists (e.g., clonidine, dexmedetomidine, guanfacine)
- Beta blockers (e.g., propranolol)
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
